WuXi PharmaTech Inc
http://www.wuxiapptec.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From WuXi PharmaTech Inc
Regulatory, Security Concerns Force Wuxi NextCODE To Cut China Ties
As China tightens its grip over clinical research using human genetic data in the country, and the US increases scrutiny over the use of personal data, multinational drug developers may face a difficult choice or even create separate entities to cater to local regulatory requirements. WuXi NextCODE provides one interesting case study.
Finance Watch: VC Mega-Rounds For Machine Learning, CNS Disorders, Academic Discoveries
Private Company Edition: Arvelle, insitro, AbCellera and the University of Michigan have something in common – they each attracted more than $100m in venture capital investment.
Coronavirus Update: R&D Starts, Product Delays, Continuing Collaboration
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.
Venture Funding Deals: ALX Oncology, Transcenta Break $100m Barrier With Recent Rounds
Recent venture capital rounds funded the start-ups Airway, Alladapt, ALX Oncology, Azafaros, CANbridge, NeoTx, Spruce and Transcenta.
Company Information
- Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Laboratory Testing Services
- Medical Devices
- Pharmaceuticals
- Services
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Crelux GmbH
- Faxian Therapeutics
- JW Biotechnology (Shanghai) Co., Ltd
- ResearchPoint Global
- STA Pharmaceutical Co., Ltd.
- WuXi AppTec
- WuXi Merger Limited
- XenoBiotic Laboratories, Inc.